Long-term outcomes following bioresorbable vascular scaffolds

被引:0
作者
Miyashita, Kotaro [1 ,2 ]
Ninomiya, Kai [1 ,2 ]
Tobe, Akihiro [1 ,2 ]
Masuda, Shinichiro [1 ,2 ]
Kotoku, Nozomi [1 ,2 ]
Kageyama, Shigetaka [1 ,2 ]
Revaiah, Pruthvi C. [1 ,2 ]
Tsai, Tsung-Ying [1 ,2 ]
Wang, Bo [1 ,2 ]
Garg, Scot [3 ]
Serruys, Patrick W. [1 ,2 ]
Onuma, Yoshinobu [1 ,2 ]
机构
[1] Univ Galway, Coll Med Nursing & Hlth Sci, Univ Rd, Galway H91 TK33, Ireland
[2] Univ Galway, CORRIB Res Ctr Adv Imaging & Core Lab, Galway, Ireland
[3] Royal Blackburn Hosp, Dept Cardiol, Blackburn, England
关键词
Drug-eluting stents; bioresorbable scaffold; new generation scaffold; long term outcomes for bioresorbable scaffold; peripheral artery disease; CORONARY-ARTERY-DISEASE; EVEROLIMUS-ELUTING STENTS; OPTICAL COHERENCE TOMOGRAPHY; 2-YEAR CLINICAL-OUTCOMES; METALLIC STENT; 1ST-IN-HUMAN EVALUATION; IMAGING OUTCOMES; ABSORB; IMPLANTATION; LESIONS;
D O I
10.1080/14779072.2024.2375340
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionThe higher scaffold thrombosis rates observed with the first-generation bioresorbable scaffolds (BRSs) compared to conventional drug-eluting stents were likely due in part to bioresorbable polymers having insufficient radial strength, necessitating larger strut profiles. Meta-analysis of the long-term outcomes from the first-generation Absorb bioresorbable vascular scaffold (BVS) showed that this period of excess risk ended at 3 years. Therefore, current attention has been focused on improving early outcomes by increasing the scaffold's tensile strength and reducing strut thickness.Areas coveredThis review summaries the lessons learned from the first-generation BRS. It updates the long-term clinical outcomes of trials evaluating the ABSORB BVS and metallic alloy-based BRS. In addition, it reviews the next-generation BRSs manufactured in Asia.Expert opinionCritical areas to improve the performance and safety of biodegradable scaffolds include further development in material science, surface modification, delivery systems, and long-term follow-up studies.
引用
收藏
页码:391 / 407
页数:17
相关论文
共 112 条
[1]   6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold The FANTOM II Study [J].
Abizaid, Alexandre ;
Carrie, Didier ;
Frey, Norbert ;
Lutz, Matthias ;
Weber-Albers, Joachim ;
Dudek, Darius ;
Chevalier, Bernard ;
Weng, Shu-Chuan ;
Costa, Ricardo A. ;
Anderson, Jeffrey ;
Stone, Gregg W. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (18) :1832-1838
[2]   Long-Term Performance of the Magmaris Drug-Eluting Bioresorbable Metallic Scaffold in All-Comers Patients' Population [J].
Al Nooryani, Arif ;
Aboushokka, Wael ;
AlBaba, Bassam ;
Kerfes, Jalal ;
Abudaqa, Loai ;
Bhatia, Amit ;
Mansoor, Anoop ;
Nageeb, Ruwaide ;
Aleksandric, Srdjan ;
Beleslin, Branko .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
[3]   Long-term clinical, angiographic, and optical coherence tomography findings of Mg-based bioresorbable scaffold in patients with acute coronary syndrome [J].
Alejandro, Gutierrez-Barrios ;
Gheorghe, Livia Luciana ;
Freire, Santiago Camacho ;
Silva, Etel ;
Menchero, Antonio Gomez ;
Francisco Jose, Morales Ponce ;
Pruano, Dolores Canadas ;
Capoccioni, Uriel Martinez ;
Lara, Josep Gomez ;
Del Pino, Teresa Bretones ;
Perez, German Calle .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 98 (01) :E69-E77
[4]   2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy [J].
Ali, Ziad A. ;
Serruys, Patrick W. ;
Kimura, Takeshi ;
Gao, Runlin ;
Ellis, Stephen G. ;
Kereiakes, Dean J. ;
Onuma, Yoshinobu ;
Simonton, Charles ;
Zhang, Zhen ;
Stone, Gregg W. .
LANCET, 2017, 390 (10096) :760-772
[5]   Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trial [J].
Arroyo, Diego ;
Gendre, Gregoire ;
Schukraft, Sara ;
Kallinikou, Zacharenia ;
Mueller, Olivier ;
Baeriswyl, Gerard ;
Stauffer, Jean-Christophe ;
Goy, Jean-Jacques ;
Togni, Mario ;
Cook, Stephane ;
Puricel, Serban .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 243 :121-125
[6]   Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial [J].
Arroyo, Diego ;
Togni, Mario ;
Puricel, Serban ;
Gerard, Baeriswyl ;
Sonja, Lehmann ;
Corpataux, Noe ;
Villeneuve, Helene ;
Boute, Estelle ;
Stauffer, Jean-Christophe ;
Goy, Jean-Jacques ;
Cook, Stephane .
TRIALS, 2014, 15
[7]   Treating arrhythmias with adjunctive magnesium: identifying future research directions [J].
Baker, William L. .
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2017, 3 (02) :108-117
[8]   Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects [J].
Blachutzik, Florian ;
Boeder, Niklas ;
Wiebe, Jens ;
Mattesini, Alessio ;
Doerr, Oliver ;
Most, Astrid ;
Bauer, Timm ;
Roether, Jens ;
Troebs, Monique ;
Schlundt, Christian ;
Achenbach, Stephan ;
Hamm, Christian W. ;
Nef, Holger M. .
CLINICAL RESEARCH IN CARDIOLOGY, 2017, 106 (04) :271-279
[9]   Acute Mechanical Performance of Magmaris vs. DESolve Bioresorbable Scaffolds in a Real-World Scenario [J].
Boeder, Niklas F. ;
Doerr, Oliver ;
Koepp, Tim ;
Blachutzik, Florian ;
Achenbach, Stephan ;
Elsaesser, Albrecht ;
Hamm, Christian W. ;
Nef, Holger M. .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
[10]   Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100 [J].
Boeder, Niklas F. ;
Doerr, Oliver ;
Bauer, Timm ;
Mattesini, Alessio ;
Elsaesser, Albrecht ;
Liebetrau, Christoph ;
Achenbach, Stephan ;
Hamm, Christian W. ;
Nef, Holger M. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 246 :74-79